Why the study?
Evidence guiding device selection between LOT-ICD and LOT-CRT remains limited in the absence of randomized trial results.
Does conduction system pacing-based CRT (LOT-CRT/LOT-ICD) improve clinical and echocardiographic outcomes compared to conventional biventricular CRT in patients with standard CRT indications?
Observational (n=111)
Does conduction system pacing-based CRT (LOT-CRT/LOT-ICD) improve clinical and echocardiographic outcomes compared to conventional biventricular CRT in patients with standard CRT indications?
Answers are grounded in this paper and cite their sources.
LBBAP-optimized CRT (LOT-CRT) is associated with superior clinical outcomes and more favorable echocardiographic remodeling compared to LOT-ICD or conventional biventricular CRT.
Background/Introduction Left bundle branch area pacing (LBBAP)–optimized (LOT) pacing modalities are emerging therapeutic strategies for cardiac resynchronization therapy (CRT). Both LOT-ICD and LOT-CRT approaches might have key roles in the future of resynchronization, but evidence guiding device selection for the individual patient remains limited in the absence of randomized trial results. Purpose This study aimed to compare clinical and echocardiographic outcomes between conduction system pacing–based CRT (CSP-CRT) and conventional biventricular CRT (Biv-CRT), and to identify predictors of response within the CSP-CRT cohort. Methods In this observational study, 51 consecutive patients with standard CRT indication underwent CSP-CRT procedure. Inverse probability of treatment weighting (IPTW) was applied to balance covariates between CSP-CRT and Biv-CRT cohort (n = 60). The CSP-CRT group was further divided into LOT-CRT (n = 27) and LOT-ICD (n = 24) subgroups. Follow-up was 24 months. The primary endpoint was comparison of composite of all-cause mortality and heart failure hospitalization; the secondary endpoint was comparison of echocardiographic response between groups. Results Baseline characteristics were not statistically different between CSP-CRT and Biv-CRT groups. Compared with LOT-ICD, LOT-CRT patients had larger LVEDD (65 ± 9 mm vs. 57.8 ± 7 mm; p = 0.035), worse NYHA class (3.0 ± 0.5 vs. 2.8 ± 0.6; p = 0.032), and a higher prevalence of prior myocardial infarction (14 vs. 8; p = 0.028). LOT-CRT achieved greater paced QRS narrowing (41 ± 16 ms vs. 32 ± 14 ms vs. 28 ± 18 ms; p = 0.024), while V6 RWPT did not differ significantly between LOT-CRT and LOT-ICD but was shorter than in Biv-CRT. LOT-CRT and selected LOT-ICD patients without septal scar on MRI had improved clinical outcomes (log-rank p = 0.016). Perioperative reductions in V6 RWPT and paced QRS duration predicted lower event rates during follow-up period (AUC = 0.891, 95% CI: 0.82–0.95; p < 0.001). Echocardiographic improvement was greater in LOT-CRT, with higher LVEF gain (13.3 ± 4.5% vs. 10 ± 4% vs. 8.5 ± 7.4%; p = 0.045) and larger LVESD reduction (20.5 ± 5% vs. 16.4 ± 4.8% vs. 16.5 ± 3%; p = 0.001). Multivariate analysis showed that LOT-CRT was an independent predictor of echocardiographic super-response (OR = 11.35, 95% CI: 1.58–82.5; p = 0.006). Conclusions In this observational cohort, LOT-CRT implantation was associated with superior clinical outcomes and more favorable echocardiographic remodeling compared with LOT-ICD or conventional Biv-CRT. These findings underscore the importance of preoperative cardiac MRI and detailed scar burden assessment to guide individualized device selection in cardiac resynchronization therapy.
No takes yet. Share an insight, caveat, or question.
Ezer et al. (2026) conducted an observational in standard CRT indication (n=111). Conduction system pacing-based CRT (CSP-CRT) vs. Conventional biventricular CRT (Biv-CRT) was evaluated on Composite of all-cause mortality and heart failure hospitalization (p=0.016).
Synapse has enriched 10 related papers. Consider them for comparative context: